GL1X · GenesisL1 explorer

Research workbench

Crystal structure of HIV-1 reverse transcriptase in complex with 8-(2- (2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-YL)ETHOXY)PHENOXY) indolizine-2-carbonitrile (JLJ555), a non-nucleoside inhibitor

Analyse Crystal structure of HIV-1 reverse transcriptase in complex with 8-(2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4MFB
Type
protein
Length
957 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 reverse transcriptase, P66 subunit; HIV-1 reverse transcriptase, P51 subunit
EC
2.7.7.49
UniProt
P03366
Ligands
29T
Pockets
14 · best druggability 0.78

Structure

x-ray diffraction · 2 distinct chains · 33% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHIV-1 reverse transcriptase, P66 subunit (EC 2.7.7.49)protein54430% helix, 22% strandP03366
BHIV-1 reverse transcriptase, P51 subunit (EC 2.7.7.49)protein41337% helix, 19% strandP03366

Ligands and binding sites

  • 29T · 8-{2-[2-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)ethoxy]phenoxy}indolizine-2-carbonitrile · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

14 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111580.780.80111empty
27460.750.807629T
35600.700.7952empty
42700.660.8238empty
54040.660.7949empty

Interfaces

1 interface between chains.

  • A–B · 2492 Ų buried · 24 hydrogen bonds · protein-protein

Compared structures

  • 4MFB · Crystal Structure of HIV-1 Reverse Transcriptase in Complex with… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.